ACM
INFI

AIGH Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

AIGH Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,650,256
Closed -$5.33M – 60
2021
Q1 		$5.33M Buy
+1,650,256
New +$5.51M 1.12% 26

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

AIGH Capital Management's INFI Position: Q2 2021 in Review

AIGH Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2021, closing a stake of 1,650,256 shares — an estimated $5.33M sold.

AIGH Capital Management first reported a position in INFI in Q1 2021 and held it in 1 quarter. The position peaked at $5.33M in Q1 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q2 2021.

  • AIGH Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • AIGH Capital Management sold 1,650,256 Infinity Pharmaceuticals, Inc. shares in Q2 2021, an estimated $5.33M.
  • AIGH Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
  • AIGH Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $5.33M in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2021.

Based on AIGH Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.